MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 177 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $469,000 | -6.2% | 31,500 | +0.2% | 0.03% | -13.3% |
| Q2 2018 | $500,000 | +12.4% | 31,425 | +0.3% | 0.03% | +11.1% |
| Q1 2018 | $445,000 | +4.0% | 31,340 | +2.5% | 0.03% | +3.8% |
| Q4 2017 | $428,000 | +19.9% | 30,565 | +22.3% | 0.03% | +13.0% |
| Q3 2017 | $357,000 | -2.2% | 24,985 | +7.8% | 0.02% | -8.0% |
| Q2 2017 | $365,000 | +26.3% | 23,180 | +10.6% | 0.02% | +19.0% |
| Q1 2017 | $289,000 | -19.7% | 20,965 | +2.9% | 0.02% | -25.0% |
| Q4 2016 | $360,000 | -10.4% | 20,366 | -2.3% | 0.03% | -17.6% |
| Q3 2016 | $402,000 | +1.8% | 20,850 | +2.8% | 0.03% | -2.9% |
| Q2 2016 | $395,000 | +8.5% | 20,275 | +14.7% | 0.04% | -2.8% |
| Q1 2016 | $364,000 | -9.2% | 17,675 | -9.6% | 0.04% | -7.7% |
| Q4 2015 | $401,000 | +41.2% | 19,550 | +31.4% | 0.04% | -2.5% |
| Q1 2015 | $284,000 | +56.0% | 14,875 | +34.6% | 0.04% | +53.8% |
| Q4 2014 | $182,000 | – | 11,050 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 283,983 | $6,299,000 | 3.15% |
| Euclidean Technologies Management, LLC | 128,088 | $2,841,000 | 2.26% |
| GLOBEFLEX CAPITAL L P | 185,939 | $4,124,000 | 0.74% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,194,000 | 0.66% |
| CLARK ESTATES INC/NY | 220,000 | $4,880,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,424,274 | $31,590,000 | 0.56% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 789,827 | $17,518,000 | 0.53% |
| EARNEST PARTNERS LLC | 3,885,748 | $86,186,000 | 0.51% |
| MOODY ALDRICH PARTNERS LLC | 137,075 | $3,040,000 | 0.43% |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 414,323 | $9,190,000 | 0.33% |